Taconic Biosciences
Generated 5/11/2026
Executive Summary
Taconic Biosciences is a global provider of genetically engineered rodent models and associated research services, supporting preclinical drug discovery and development. Founded in 1952 and headquartered in Ry, Denmark, the company offers a wide range of off-the-shelf and custom mouse and rat models for therapeutic areas including oncology, immunology, metabolic disease, and neuroscience. With facilities in North America and Europe, Taconic ensures standardized model production and distribution for the international scientific community. The company is privately held and has secured funding to support its operations and growth. Its services extend to breeding, health monitoring, cryopreservation, and custom model generation, making it a key partner for pharmaceutical and biotechnology companies.
Upcoming Catalysts (preview)
- TBDLaunch of next-generation humanized mouse models for immuno-oncology70% success
- TBDStrategic partnership with a top pharma company for custom model development60% success
- TBDExpansion of European production facility to meet growing demand50% success
- · Pipeline Analysis
- · Competitive Landscape
- · Catalyst Calendar (full 12-month)
- · Bull Case
- · Bear Case
- · Counterfactual Scenarios
- · Valuation Notes
- · SEC Filing Highlights
- · Insider Activity
- · Literature Watch
- · Patent Landscape
- · Mechanism Cluster Map
- · Audio Briefing (5 min)